# Artemether-Lumefantrine (AL) Unit Dose Pre-packs Versus Blister Packs

> **NCT01065116** · PHASE3 · COMPLETED · sponsor: **Malaria Consortium, Uganda** · enrollment: 920 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** AL Blister-packs with Instruction leaflets
- **DRUG:** AL unit dose age specific pre-packs

## Key facts

- **NCT ID:** NCT01065116
- **Lead sponsor:** Malaria Consortium, Uganda
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 920 (ACTUAL)
- **Last updated:** 2011-07-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01065116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01065116, "Artemether-Lumefantrine (AL) Unit Dose Pre-packs Versus Blister Packs". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01065116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*